IL25 and idiopathic pulmonary fibrosis: In the subgroup of IPF patients treated with pirfenidone we noted significantly decreased IL-25 EBC follow-up levels (81.80 (66.80–91.47) pg/mL) compared to baseline levels (173.13 (149.80-180.47) pg/mL; p < 0.0001).